menu search

LPCN / Lipocine to Present at the H.C. Wainwright Annual NASH Investor Conference

Lipocine to Present at the H.C. Wainwright Annual NASH Investor Conference
SALT LAKE CITY , Oct. 23, 2023 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) disorders, today announced that it will present and meet with investors at the H.C. Wainwright 7th Annual NASH Investor Conference, taking place virtually October 24, 2023. Read More
Posted: Oct 23 2023, 19:00
Author Name: PRNewsWire
Views: 110870

LPCN News  

Lipocine to Present at the H.C. Wainwright Annual NASH Investor Conference

By PRNewsWire
October 23, 2023

Lipocine to Present at the H.C. Wainwright Annual NASH Investor Conference

SALT LAKE CITY , Oct. 23, 2023 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (C more_horizontal

Lipocine to Present at Biotech Showcase

By PRNewsWire
January 5, 2023

Lipocine to Present at Biotech Showcase

Company Management Will Also Host Meetings at LifeSci Partners Corporate Access Event SALT LAKE CITY , Jan. 5, 2023 /PRNewswire/ -- Lipocine Inc. (NAS more_horizontal


Search within

Pages Search Results: